| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/22/2004 | EP1458754A2 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
| 09/22/2004 | EP1458753A1 Modified bacterial surface layer proteins |
| 09/22/2004 | EP1458752A2 Polypeptides of pseudomonas aeruginosa |
| 09/22/2004 | EP1458749A2 Bone polypeptide-1 |
| 09/22/2004 | EP1458748A2 Apoptotically active peptides |
| 09/22/2004 | EP1458747A1 Template-fixed peptidomimetics as inhibitors of serine proteases |
| 09/22/2004 | EP1458746A2 Cyclic tetrapeptide compound and use thereof |
| 09/22/2004 | EP1458745A2 SUBSTITUTED AMINO CARBOXAMIDES FOR THE TREATMENT OF ALZHEIMER'S DISEASE |
| 09/22/2004 | EP1458741A2 Rna interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid |
| 09/22/2004 | EP1458739A2 Antisense modulation of human fxr expression |
| 09/22/2004 | EP1458427A2 Compositions comprising collagen and metalloprotease inhibitors |
| 09/22/2004 | EP1458425A2 A hemostatic kit, a method of preparing a hemostatic agent and a method of promoting hemostasis |
| 09/22/2004 | EP1458411A2 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 09/22/2004 | EP1458410A2 Stabilised mrna tumour vaccine |
| 09/22/2004 | EP1458408A1 Liquid composition of factor vii polypeptides |
| 09/22/2004 | EP1458407A1 Liquid composition of modified factor vii polypeptides |
| 09/22/2004 | EP1458406A1 A method of treatment and agents useful for same |
| 09/22/2004 | EP1458405A1 Use of fk506 and analogues for treating allergic diseases |
| 09/22/2004 | EP1458404A1 Polyphenol inhibition of nucleoside diphosphate kinase-b activity and cancer metastasis |
| 09/22/2004 | EP1458403A2 Compositions and methods for the treatment and clinical remission of psoriasis |
| 09/22/2004 | EP1458397A1 Use of therapeutic dosages for nitric oxide donors which do not significantly lower blood pressure or pulmonary artery pressure |
| 09/22/2004 | EP1458393A1 Substituted diketopiperazines as oxytocin antagonists |
| 09/22/2004 | EP1458371A1 Pyruvate cardioplegia solutions for administration to the heart during cardiopulmonary surgery and methods of use thereof |
| 09/22/2004 | EP1458362A2 Pharmaceutical compositions in particulate form |
| 09/22/2004 | EP1458361A2 Compositions for sustained action product delivery |
| 09/22/2004 | EP1458359A1 Microemulsion preconcentrate |
| 09/22/2004 | EP1458352A1 Solid dose micro implant |
| 09/22/2004 | EP1458349A1 Composition comprising at least an oxazolin for inhibiting langerhans cell migration, and uses thereof |
| 09/22/2004 | EP1458347A2 Composition comprising at least an alkanolamide for inhibiting langerhans cell migration, and uses thereof |
| 09/22/2004 | EP1458247A2 Malleable protein matrix and uses thereof |
| 09/22/2004 | EP1458241A2 Modified antigen-presenting cells |
| 09/22/2004 | EP1458240A2 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 09/22/2004 | EP1408876A4 Zero-order prolonged release coaxial implants |
| 09/22/2004 | EP1370240A4 Neuroprotectants formulations and methods |
| 09/22/2004 | EP1350104A4 Presenilin enhancers |
| 09/22/2004 | EP1259598B1 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor |
| 09/22/2004 | EP1207859B1 Oral form of administration containing probiotic micro-organisms |
| 09/22/2004 | EP1163264B1 Novel lhrh antagonists with improved solubility characteristics |
| 09/22/2004 | EP1140981B1 Tripeptide compounds useful as selective inhibitors of aminopeptidase a and corresponding pharmaceutical compositions |
| 09/22/2004 | EP1096955B1 Uses of antibodies to aminophospholipids for cancer treatment |
| 09/22/2004 | EP1069118B1 Process for producing 4-thiazolylmethyl derivative |
| 09/22/2004 | EP1012164B1 Serine protease inhibitors |
| 09/22/2004 | EP1009756B1 RECOMBINANT IgA |
| 09/22/2004 | EP1007691B1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids |
| 09/22/2004 | EP1005539B1 Ikk-alpha proteins, nucleic acids and methods |
| 09/22/2004 | EP1001750B1 Stable particulate complexes with neutral or negative globale charge of lamellar structure |
| 09/22/2004 | EP0990044B1 A method for in vitro molecular evolution of protein function |
| 09/22/2004 | EP0941121B1 Stable lyophilized pharmaceutical substances from monoclonal or polyclonal antibodies |
| 09/22/2004 | EP0938500B1 INTERLEUKIN-1beta-CONVERTING ENZYME (ICE) INHIBITING PEPTIDES |
| 09/22/2004 | EP0866800B1 Antineoplastic peptides |
| 09/22/2004 | EP0831882B1 Reconstituted collagen fiber segment compositions and methods of preparation thereof |
| 09/22/2004 | EP0737207B1 Inhibitors of human plasmin derived from the kunitz domains |
| 09/22/2004 | EP0726914B1 Cell surface protein expressed on human cortical thymocyte and their use |
| 09/22/2004 | EP0706575B1 Retroviral vectors for transducing beta-globin gene and beta-locus control region derivatives |
| 09/22/2004 | EP0682708B1 Antiviral composition of viral protein trans-dominant variants |
| 09/22/2004 | EP0587805B2 Bovine herpesvirus type 1 deletion mutants, vaccines based thereon, diagnostic kits for detection of bovine herpesvirus type 1 |
| 09/22/2004 | CN1531653A Method for identification of proteins from intracellular bacteria |
| 09/22/2004 | CN1531600A New polynucleotides and polypeptides of IFN 2-21 gene |
| 09/22/2004 | CN1531592A Process for preparation of neutrophil inhibitory factor |
| 09/22/2004 | CN1531554A Humanized antibodies derived from DD-3B6-22, specific for D-dimer fragment of fibrin |
| 09/22/2004 | CN1531552A Chimeric proteins for cell targeting and apoptosis induction and methods of using same |
| 09/22/2004 | CN1531550A Heterocarpine, human GHRH-binding protein |
| 09/22/2004 | CN1531549A Pharmaceutical use for secreted bacterial effector proteins |
| 09/22/2004 | CN1531547A Hepatitis C tripeptide inhibitors |
| 09/22/2004 | CN1531546A Peptide compounds |
| 09/22/2004 | CN1531545A Reducing immunogenicity of fusion proteins |
| 09/22/2004 | CN1531444A Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using same |
| 09/22/2004 | CN1531441A Pharmaceutical compositinos which inhibit vascular proliferation and method of use thereof |
| 09/22/2004 | CN1531440A Pharmaceutical composition for preventing or treating TH1 and TH2 cell related diseases by modulating TH/TH2 ratio |
| 09/22/2004 | CN1531439A Liposome targeting of matrix metalloproteinase inhibitors |
| 09/22/2004 | CN1531438A Normalization of defective T cell responsiveness through manipulation of thymic regeneration |
| 09/22/2004 | CN1531422A Gene delivery formulations and methods for treatment of ischemic conditions |
| 09/22/2004 | CN1531419A In-situ gel formation of pectins |
| 09/22/2004 | CN1530444A Gene related to blood sugar regulation, protein product and use thereof |
| 09/22/2004 | CN1530372A Inhibitor of hecterocyclic oxoaminoethylol aminosulfonic amine reverse transcripted virus protenase |
| 09/22/2004 | CN1530138A Stabilized medicine preparation form with by porous kietyoite covering flavour |
| 09/22/2004 | CN1530137A Health food for diabetes patients |
| 09/22/2004 | CN1530136A Medicine feeding method for antibiotics |
| 09/22/2004 | CN1530135A Immune activator |
| 09/22/2004 | CN1530107A Insulin resistance treatment by growth hormone secretory hormone |
| 09/22/2004 | CN1530102A Medical preparation containing alpha-thioctan, ambroxol and/or ACE inhibiting agent and its use in treating neurodegenerative diseases |
| 09/22/2004 | CN1167799C Method for secreting and expressing acid fibroblast growth factor |
| 09/22/2004 | CN1167795C Novel peptide, novel DNA and novel antibody |
| 09/22/2004 | CN1167793C Polypeptides encoded by human lipase-like gene, compositions and methods |
| 09/22/2004 | CN1167710C Pyrrolidincarbonylamino cyclic disulfides |
| 09/22/2004 | CN1167466C Oral medicinal preparation |
| 09/22/2004 | CN1167464C Medicine for artificially inducing rockfish's sex reversion and its preparation |
| 09/22/2004 | CN1167463C Preparation of medicines for diseases in peripheral nerve system and male genetic defects |
| 09/22/2004 | CN1167462C Medicinal composition containing cyclosporin |
| 09/22/2004 | CN1167358C Nutritional composition for treating pressure ulcers |
| 09/21/2004 | US6795776 Crystallographic structure of the androgen receptor ligand binding domain |
| 09/21/2004 | US6794545 Conformationally restricted polyamine analogs as disease therapies |
| 09/21/2004 | US6794501 Colon cancer antigen panel |
| 09/21/2004 | US6794500 RNA-binding protein |
| 09/21/2004 | US6794495 For the cytotoxic enhancement of lymphocytes; immunotherapy; immunostimulants |
| 09/21/2004 | US6794493 Amino acid sequence of antithrombin having an h-helix modified by at least one amino acid to have a more positive charge than non-modified antithrombin; treats hemophilia by improving bioavailability of coagulation factor v, viii and x |
| 09/21/2004 | US6794491 Polypeptides, their production and use |
| 09/21/2004 | US6794490 Lipopeptides as antibacterial agents |
| 09/21/2004 | US6794489 Peptide sequence ac-nle-cyclo(-asp-his-d-phe-arg-trp-lys)-oh derived from a melanocyte-stimulating hormone (? alpha -msh?) analog, called melanotan-ii |
| 09/21/2004 | US6794414 Method and compositions for treating diseases mediated by transglutaminase activity |